RITUXIMAB

Approval Year

Show entries

Name

Type

Language

RITUXIMAB

Official Name

English

IDEC-C 2B8

Code

English

RITUXIMAB COMPONENT OF RITUXAN HYCELA

Brand Name

English

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Common Name

English

RITUXIMAB (GENETICAL RECOMBINATION)

Official Name

English

Showing 1 to 5 of 21 entries

Previous1 2 3 4 5Next

Show entries

Classification Tree

Code System

Code

RHEUMATIC DISEASES

EMA ASSESSMENT REPORTS

MABTHERA (AUTHORIZED: ARTHRITIS, RHEUMATOID)

LEUKEMIA, B-CELL

EMA ASSESSMENT REPORTS

MABTHERA (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)

Designated/Approved

FDA ORPHAN DRUG

177603

Designated

FDA ORPHAN DRUG

923822

Antibody-Surface Protein Interactions

NDF-RT

N0000175078

Showing 1 to 5 of 24 entries

Previous1 2 3 4 5Next

Show entries

Code System

Code

Type

Description

IUPHAR

6780

PRIMARY

MERCK INDEX

m9637

PRIMARY

Merck Index

SMS_ID

100000089292

PRIMARY

DRUG BANK

DB00073

PRIMARY

RXCUI

2273510

ALTERNATIVE

Showing 1 to 5 of 24 entries

Previous1 2 3 4 5Next

Subunit 0

Subunit 1

Subunit 2

Subunit 3

ACTIVE MOIETY


					4F4X42SYQ6

RITUXIMAB